Condition 1: Multiple sclerosis. Condition 2: Neurasthenia. Multiple sclerosis Neurasthenia
Conditions
Interventions
Intervention 1: Control group: Interferon (main treatment) with placebo capsules (twice daily) for one month. Intervention 2: Treatment group: Interferon (main treatment) with grape seed capsules (tw
Treatment - Drugs
Control group: Interferon (main treatment) with placebo capsules (twice daily) for one month
Treatment group: Interferon (main treatment) with grape seed capsules (twice daily) for one month, each capsule contained 300 mg extract
Sponsors
Ahvaz Jundishapur University of Medical Sciences, medicinal plants research center
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: MS patients have fatigue; No other neurological disease; No Diseases like diabetes and autoimmune diseases; No new attack in the last month Exclusion criteria: Emergence of drug side effects; New disease attack; Do not take medicine for one week; Pregnancy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MFIS. Timepoint: Start intervention and a month later. Method of measurement: MFIS questionnaire.;MSQL-54. Timepoint: Start intervention and a month later. Method of measurement: MSQL-54 questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: One month after the intervention began. Method of measurement: observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir siahpoosh
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed